• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

革新年龄相关性黄斑变性的患者监测:AMD VIEWER必要性与效率的比较研究

Revolutionizing Patient Monitoring in Age-Related Macular Degeneration: A Comparative Study on the Necessity and Efficiency of the AMD VIEWER.

作者信息

Tabuchi Hitoshi, Yamauchi Tomofusa, Nagasawa Toshihiko, Deguchi Hodaka, Tanabe Mao, Tanaka Hayato, Yasukawa Tsutomu

机构信息

Department of Technology and Design Thinking for Medicine, Hiroshima University, Hiroshima 734-0037, Japan.

Department of Ophthalmology, Tsukazaki Hospital, Himeji 671-1227, Japan.

出版信息

Bioengineering (Basel). 2023 Dec 15;10(12):1426. doi: 10.3390/bioengineering10121426.

DOI:10.3390/bioengineering10121426
PMID:38136017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10740730/
Abstract

(1) Background: Age-related Macular Degeneration (AMD) is a critical condition leading to blindness, necessitating lifelong clinic visits for management, albeit with existing challenges in monitoring its long-term progression. This study introduced and assessed an innovative tool, the AMD long-term Information Viewer (AMD VIEWER), designed to offer a comprehensive display of crucial medical data-including visual acuity, central retinal thickness, macular volume, vitreous injection treatment history, and Optical Coherent Tomography (OCT) images-across an individual eye's entire treatment course. (2) Methods: By analyzing visit frequencies of patients with a history of invasive AMD treatment, a comparative examination between a Dropout group and an Active group underscored the clinical importance of regular visits, particularly highlighting better treatment outcomes and maintained visual acuity in the Active group. (3) Results: The efficiency of AMD VIEWER was proven by comparing it to manual data input by optometrists, showing significantly faster data display with no errors, unlike the time-consuming and error-prone manual entries. Furthermore, an elicited Net Promoter Score (NPS) of 70 from 10 ophthalmologists strongly endorsed AMD VIEWER's practical utility. (4) Conclusions: This study underscores the importance of regular clinic visits for AMD patients. It suggests the AMD VIEWER as an effective tool for improving treatment data management and display.

摘要

(1)背景:年龄相关性黄斑变性(AMD)是一种导致失明的严重疾病,需要终身就诊进行管理,尽管在监测其长期进展方面存在现有挑战。本研究引入并评估了一种创新工具,即AMD长期信息查看器(AMD VIEWER),旨在全面展示关键医学数据,包括视力、视网膜中央厚度、黄斑体积、玻璃体注射治疗史以及光学相干断层扫描(OCT)图像,贯穿个体眼睛的整个治疗过程。(2)方法:通过分析有侵入性AMD治疗史患者的就诊频率,对失访组和活跃组进行比较检查,强调了定期就诊的临床重要性,尤其突出了活跃组更好的治疗效果和维持的视力。(3)结果:将AMD VIEWER与验光师手动输入数据进行比较,证明了其效率,显示数据显示明显更快且无错误,不像耗时且容易出错的手动输入。此外,10位眼科医生给出的净推荐值(NPS)为70,强烈认可了AMD VIEWER的实际效用。(4)结论:本研究强调了AMD患者定期就诊的重要性。它表明AMD VIEWER是改善治疗数据管理和展示的有效工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de14/10740730/1fdc4a006363/bioengineering-10-01426-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de14/10740730/7758b23429f0/bioengineering-10-01426-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de14/10740730/be52f1451173/bioengineering-10-01426-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de14/10740730/55984a54acb8/bioengineering-10-01426-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de14/10740730/4923e98d38ab/bioengineering-10-01426-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de14/10740730/dd6d20a19cd0/bioengineering-10-01426-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de14/10740730/1fdc4a006363/bioengineering-10-01426-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de14/10740730/7758b23429f0/bioengineering-10-01426-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de14/10740730/be52f1451173/bioengineering-10-01426-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de14/10740730/55984a54acb8/bioengineering-10-01426-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de14/10740730/4923e98d38ab/bioengineering-10-01426-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de14/10740730/dd6d20a19cd0/bioengineering-10-01426-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de14/10740730/1fdc4a006363/bioengineering-10-01426-g006.jpg

相似文献

1
Revolutionizing Patient Monitoring in Age-Related Macular Degeneration: A Comparative Study on the Necessity and Efficiency of the AMD VIEWER.革新年龄相关性黄斑变性的患者监测:AMD VIEWER必要性与效率的比较研究
Bioengineering (Basel). 2023 Dec 15;10(12):1426. doi: 10.3390/bioengineering10121426.
2
Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study.老年人群中未受影响的第二眼新生血管性黄斑变性的早期无创性检测:EDNA 诊断准确性研究。
Health Technol Assess. 2022 Jan;26(8):1-142. doi: 10.3310/VLFL1739.
3
Optical Coherence Tomography Monitoring Strategies for A-VEGF-Treated Age-Related Macular Degeneration: An Evidence-Based Analysis.抗血管内皮生长因子治疗年龄相关性黄斑变性的光学相干断层扫描监测策略:一项基于证据的分析。
Ont Health Technol Assess Ser. 2014 Aug 1;14(10):1-64. eCollection 2014.
4
[New examination methods for macular disorders--application of diagnosis and treatment].[黄斑疾病的新检查方法——诊断与治疗的应用]
Nippon Ganka Gakkai Zasshi. 2000 Dec;104(12):899-942.
5
Clinical audit as an educative tool for optometrists: an intervention study in age-related macular degeneration.临床审核作为视光师的教育工具:一项与年龄相关性黄斑变性相关的干预研究。
Ophthalmic Physiol Opt. 2021 Jan;41(1):53-72. doi: 10.1111/opo.12754. Epub 2020 Nov 6.
6
Age related macular degeneration and visual disability.年龄相关性黄斑变性与视力障碍。
Curr Drug Targets. 2011 Feb;12(2):221-33. doi: 10.2174/138945011794182755.
7
The importance of monitoring wet age-related macular degeneration patients during Coronavirus disease 19 pandemic: A retrospective study of assessment of functional and structural outcomes.监测湿性年龄相关性黄斑变性患者在 COVID-19 大流行期间的重要性:一项评估功能和结构结果的回顾性研究。
J Fr Ophtalmol. 2022 Oct;45(8):852-859. doi: 10.1016/j.jfo.2022.05.005. Epub 2022 Jul 6.
8
Prognostic Value of Retinal Layers in Comparison with Other Risk Factors for Conversion of Intermediate Age-related Macular Degeneration.视网膜层与其他危险因素相比对中间型年龄相关性黄斑变性转归的预测价值。
Ophthalmol Retina. 2020 Jan;4(1):31-40. doi: 10.1016/j.oret.2019.08.003. Epub 2019 Aug 20.
9
Prognostic factors associated with the course of vitreomacular traction in eyes with age-related macular degeneration.与年龄相关性黄斑变性患者玻璃体黄斑牵引病程相关的预后因素。
Photodiagnosis Photodyn Ther. 2022 Dec;40:103025. doi: 10.1016/j.pdpdt.2022.103025. Epub 2022 Jul 20.
10
Prospective evaluation of teleophthalmology in screening and recurrence monitoring of neovascular age-related macular degeneration: a randomized clinical trial.前瞻性评估远程眼科在新生血管性年龄相关性黄斑变性的筛查和复发监测中的应用:一项随机临床试验。
JAMA Ophthalmol. 2015 Mar;133(3):276-82. doi: 10.1001/jamaophthalmol.2014.5014.

本文引用的文献

1
Discontinuation of treatment and retreatment of neovascular age-related macular degeneration in the real-world: Bundang AMD cohort study report 5.现实世界中新生血管性年龄相关性黄斑变性的治疗中断与再治疗:盆唐年龄相关性黄斑变性队列研究报告5
Front Med (Lausanne). 2023 Jul 10;10:1204026. doi: 10.3389/fmed.2023.1204026. eCollection 2023.
2
Net Promoter Score (NPS): What Does Net Promoter Score Offer in the Evaluation of Continuing Medical Education?净推荐值(NPS):净推荐值在继续医学教育评估中能提供什么?
J Eur CME. 2022 Nov 29;11(1):2152941. doi: 10.1080/21614083.2022.2152941. eCollection 2022.
3
Characterisation of macular neovascularisation subtypes in age-related macular degeneration to optimise treatment outcomes.
年龄相关性黄斑变性中黄斑新生血管亚型的特征分析以优化治疗效果。
Eye (Lond). 2023 Jun;37(9):1758-1765. doi: 10.1038/s41433-022-02231-y. Epub 2022 Sep 14.
4
Prospective, multi-site study of patient outcomes after implementation of the TREWS machine learning-based early warning system for sepsis.采用 TREWS 机器学习为基础的脓毒症早期预警系统后,对患者预后的前瞻性、多中心研究。
Nat Med. 2022 Jul;28(7):1455-1460. doi: 10.1038/s41591-022-01894-0. Epub 2022 Jul 21.
5
The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice.新生血管性年龄相关性黄斑变性患者管理格局的变化:临床实践中的 brolucizumab。
Eye (Lond). 2022 Sep;36(9):1725-1734. doi: 10.1038/s41433-022-02008-3. Epub 2022 Mar 21.
6
Delivery of nVEGFi using AAV8 for the treatment of neovascular age-related macular degeneration.使用腺相关病毒8型递送新型血管内皮生长因子抑制剂用于治疗新生血管性年龄相关性黄斑变性。
Mol Ther Methods Clin Dev. 2022 Jan 10;24:210-221. doi: 10.1016/j.omtm.2022.01.002. eCollection 2022 Mar 10.
7
Association of Macular Thickness With Age and Age-Related Macular Degeneration in the Carotenoids in Age-Related Eye Disease Study 2 (CAREDS2), An Ancillary Study of the Women's Health Initiative.在妇女健康倡议的辅助研究——年龄相关性眼病研究 2(CAREDS2)中,黄斑厚度与年龄和年龄相关性黄斑变性的关系。
Transl Vis Sci Technol. 2021 Feb 5;10(2):39. doi: 10.1167/tvst.10.2.39.
8
Age-Related Macular Degeneration Revisited: From Pathology and Cellular Stress to Potential Therapies.再探年龄相关性黄斑变性:从病理与细胞应激到潜在疗法
Front Cell Dev Biol. 2021 Jan 25;8:612812. doi: 10.3389/fcell.2020.612812. eCollection 2020.
9
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.2020 年失明和视力障碍的原因及 30 多年来的趋势,以及与 VISION 2020:看见的权利相关的可避免盲的患病率:全球疾病负担研究的分析。
Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1.
10
Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration: A Mixed-Methods Systematic Review.抗 VEGF 药物治疗新生血管性年龄相关性黄斑变性的不依从或不持续治疗:一项混合方法系统评价。
Ophthalmology. 2021 Feb;128(2):234-247. doi: 10.1016/j.ophtha.2020.07.060. Epub 2020 Aug 5.